|
|
|
|
LEADER |
01095nam a2200289 i 4500 |
001 |
NSK01000926983 |
003 |
HR-ZaNSK |
005 |
20180606111834.0 |
007 |
ta |
008 |
160309s2015 au a i000 0 eng |
020 |
|
|
|a 9789201014153
|
035 |
|
|
|a (HR-ZaNSK)000926983
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
080 |
1 |
|
|a 621.039.8:616-08
|2 MRF 2011.
|
080 |
1 |
|
|a 616-006-08:621.03
|2 MRF 2011.
|
080 |
1 |
|
|a 615.84:616-006
|2 MRF 2011.
|
110 |
2 |
|
|a International Atomic Energy Agency
|
245 |
1 |
4 |
|a The transition from 2-D brachytherapy to 3-D high dose rate brachytherapy /
|c International Atomic Energy Agency.
|
260 |
|
|
|a Vienna :
|b International Atomic Energy Agency,
|c 2015.
|
300 |
|
|
|a 33 str. :
|b ilustr. (djelomice u bojama) ;
|c 30 cm.
|
490 |
0 |
|
|a IAEA human health reports,
|x 2074-7667 ;
|v no. 12
|
504 |
|
|
|a Bibliografija: str. 27-29.
|
650 |
|
7 |
|a Radioizotopna brahiterapija
|2 nskps
|
650 |
|
7 |
|a Karcinom
|x Radioterapija
|2 nskps
|
650 |
|
7 |
|a Radioterapija
|2 nskps
|
760 |
1 |
8 |
|t IAEA human health reports
|x 2074-7667
|g no. 12
|w nsk.(HR-ZaNSK)000797987
|
998 |
|
|
|m eemk1603
|c mzoo160711
|